Skip to main content
. 2019 Oct 30;79(2):276–284. doi: 10.1136/annrheumdis-2019-216154

Table 3.

Use of medication for relief of gout pain over the first week (diary days 1–7) and between weeks 2 and 4 (week 4 follow-up)

Days 1–7 Weeks 2–4
Naproxen Colchicine OR (95% CI) (p value) Naproxen Colchicine OR (95% CI) (p value)
N (%)* N (%)* Complete case* Imputed† N (%)* N (%)* Complete case* Imputed†
Paracetamol 20 (13.4) 34 (23.6) 2.09 (1.11 to 3.93)
(p=0.022)
1.91 (1.05 to 3.51)
(p=0.035)
10 (7.5) 11 (7.1) 1.12 (0.45 to 2.82)
(p=0.81)
0.98 (0.40 to 2.37)
(p=0.96)
Ibuprofen 16 (10.7) 20 (13.9) 1.54 (0.72 to 3.29)
(p=0.27)
1.58 (0.80 to 3.12)
(p=0.19)
12 (9.0) 27 (17.5) 2.34 (1.11 to 4.94)
(p=0.026)
1.93 (0.90 to 4.14)
(p=0.089)
Diclofenac 2 (1.3) 4 (2.8) 4 (3.0) 6 (3.9)
Indomethacin 1 (0.7) 0 (0.0) 2 (1.5) 5 (3.2)
Tramadol 1 (0.7) 0 (0.0) 1 (0.7) 2 (1.3)
Codeine 7 (4.7) 21 (14.6) 3.62 (1.47 to 8.93)
(p=0.005)
3.20 (1.35 to 7.57)
(p=0.008)
12 (9.0) 8 (5.2) 0.60 (0.22 to 1.65)
(p=0.32)
0.59 (0.23 to 1.50)
(p=0.27)
Prednisolone 3 (2.0) 2 (1.4) 2 (1.5) 1 (0.6)
Any analgesic or non-naproxen NSAID‡ 37 (24.8) 61 (42.4) 2.23 (1.35 to 3.66)
(p=0.001)
1.89 (1.24 to 2.88)
(p=0.003)
37 (27.6) 52 (33.8) 1.34 (0.81 to 2.21)
(p=0.26)
0.95 (0.63 to 1.43)
(p=0.81)

OR for colchicine relative to naproxen (adjusted for age, gender and baseline pain score). *Analysis of complete case data (days 1–7: n=288; five cases excluded due to missing baseline pain scores; week 4: n=283; five cases excluded due to missing baseline pain scores). †Analysis of imputed data (n=399). n/a: analysis not applicable (as it is an evaluation of compliance with allocated treatment). –, ORs not estimated due to small frequency counts.

*Complete response to medication questions: diary days 1–7—149 in naproxen group and 144 in colchicine group; week 4—134 in naproxen group and 154 in colchicine group.

†Imputed data set: 200 in naproxen group; 199 in colchicine group (full ITT analysis).

‡Paracetamol or codeine or tramadol or ibuprofen or diclofenac or indomethacin.

ITT, intention-to-treat; NSAID, non-steroidal anti-inflammatory drug.